STAMP+CBT mHealth for Cancer Pain

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-01

Study Completion Date

2023-06-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers

NCT06722014

Pain Pain Syndrome Advanced Cancer

RECRUITING NA

Psychological Intervention Using Smartphone Technology to Alleviate Malignant Pain

NCT05774197

Cancer Pain Opioid Use Cognitive Behavior Therapy

COMPLETED NA

Smartphone Technology to Alleviate Malignant Pain (STAMP)

NCT03717402

Cancer Pain Management Opioid Use

COMPLETED NA

A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities

NCT02783755

Breast Cancer

COMPLETED NA

Meaning-Centered Pain Coping Skills Training

NCT04431830

Advanced Solid Tumor Pain

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research study involves the use of a smartphone app at home in addition to surveys and potentially an interview at the end of the study.

The research study procedures include screening for eligibility, study interventions include surveys at the beginning of the study, after 4 weeks, and after 6 weeks and use of the smartphone app.

Participants will be on this research study for up to 6 weeks.

It is expected that about 15 people will take part in this research study

This research study is a Feasibility Study, which is the first-time investigators are examining this mobile application meant to help participant to learn behavioral techniques to manage cancer pain. The purpose is to make sure the app is usable and helpful for patients with cancer, and to get feedback about patient experiences after using the app for four weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Active Cancer Active Cancer Treatment Advanced Cancer Palliative Care Chronic Pain Due to Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

STAMP+CBT PILOT

Patients in this Pilot Cohort will be in the research study for 6 weeks total including:

* a 4-week intervention period and 2-week post intervention period.
* Patients will use the app for a total of 4 weeks (4-week intervention period), and will complete surveys at baseline, 4 weeks (end of intervention period), and at 6 weeks (end of 2-week post intervention period).

Group Type EXPERIMENTAL

STAMP+CBT application

Intervention Type BEHAVIORAL

Use the STAMP+CBT mobile app for 4 weeks (intervention period, 4 weeks for content introduction, extended 2 weeks for review of content if patient's request this

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

STAMP+CBT application

Use the STAMP+CBT mobile app for 4 weeks (intervention period, 4 weeks for content introduction, extended 2 weeks for review of content if patient's request this

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- PILOT COHORT

* Age ≥ 18 years
* Patients diagnosed with an active cancer diagnosis, either undergoing active cancer treatment or receiving treatment for an advanced cancer or are receiving palliative care
* Treatment managed at participating clinic (DFCI outpatient palliative care, gastrointestinal cancer center, and DFCI satellite clinic Merrimack Valley or Londonderry)
* Chronic pain related to cancer or treatment (\> pain score of 4)
* Has an active prescription for at least one opioid medication to treat their cancer pain (i.e. not for post-surgical pain)
* Own a compatible smartphone (android) or is willing to use an android device provided by the study team
* Completes baseline survey

Exclusion Criteria

* Patients in survivorship: patients who have completed their treatment regimens, are not actively receiving treatment for an advanced cancer, or have a cancer that is in remission
* Cognitive impairment that would interfere with study participation, as judged by treating clinician
* Inability to speak English: the intervention has not yet been translated to Spanish
* History of opioid use disorders
* Enrolled in hospice
* Currently hospitalized
* Use of transmucosal fentanyl, given safety concerns and ongoing risk mitigation program required to prescribe these (TIRF REMS).
* Pain primarily related to a recent surgery

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No